A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

NCT06398444 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinotau Pharmaceutical Group